Global Sarcopenia Market Size, Share, Sales Growth Analysis, 2032

Sarcopenia Market

Sarcopenia Market by Supplement Type (Protein Supplement, Vitamin D & Calcium Supplement, and Vitamin B12 Supplement) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Hypermarket & Supermarket): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 210 Report Code: ZMR-3631 Published Date: Feb-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3019.14 Million USD 4855.01 Million 5.42% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Sarcopenia Market, 2024 - 2032 (USD Million)
    • 2.2. Global Sarcopenia Market: Snapshot
  •  
  • Chapter 3. Sarcopenia Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Sarcopenia Market drivers: Impact analysis
      • 3.2.2. increased prevalence of obesity and an aging population
      • 3.2.3. increase in research and development activities
    • 3.3. Market Restraints
      • 3.3.1. Unavailability of new drugs in the market
    • 3.4. Opportunities
      • 3.4.1. High spending on R&D
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Supplement Type
      • 3.6.2. Market attractiveness analysis, by Distribution Channel
      • 3.6.3. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Sarcopenia Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Sarcopenia Market: company market share, 2024
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Supplement Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Sarcopenia Market - Supplement Type Segment Analysis
    • 5.1. Global Sarcopenia Market: Supplement Type overview
      • 5.1.1. Global Sarcopenia Market revenue share, by Supplement Type, 2024 and 2032(USD Million)
    • 5.2. Protein Supplement
      • 5.2.1. Global Protein Supplement market, 2024 - 2032(USD Million)
    • 5.3. Vitamin D & Calcium Supplement
      • 5.3.1. Global Vitamin D & Calcium Supplement market, 2024 - 2032(USD Million)
    • 5.4. Vitamin B12 Supplement
      • 5.4.1. Global Vitamin B12 Supplement market, 2024 - 2032(USD Million)
  •  
  • Chapter 6. Global Sarcopenia Market - Distribution Channel Segment Analysis
    • 6.1. Global Sarcopenia Market: Distribution Channel overview
      • 6.1.1. Global Sarcopenia Market revenue share, by Distribution Channel, 2014 and 2032(USD Million)
    • 6.2. Hospital Pharmacies
      • 6.2.1. Global Sarcopenia Market for Hospital Pharmacies, 2024 - 2032(USD Million)
    • 6.3. Retail Pharmacies
      • 6.3.1. Global Sarcopenia Market for Retail Pharmacies, 2024 - 2032(USD Million)
    • 6.4. Online Pharmacies
      • 6.4.1. Global Sarcopenia Market for Online Pharmacies, 2024 - 2032(USD Million)
    • 6.5. Hypermarket & Supermarket
      • 6.5.1. Global Sarcopenia Market for Hypermarket & Supermarket, 2024 - 2032(USD Million)
  •  
  • Chapter 7. Global Sarcopenia Market - Regional Segment Analysis
    • 7.1. Global Sarcopenia Market: Regional overview
      • 7.1.1. Global Sarcopenia Market revenue share, by Region, 2024 and 2032
    • 7.2. North America
      • 7.2.1. North America Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
      • 7.2.2. North America Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
      • 7.2.3. North America Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.2.4.2. The U.S. Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.2.4.3. The U.S. Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.2.5.2. Rest of North America Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.2.5.3. Rest of North America Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
      • 7.3.2. Europe Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
      • 7.3.3. Europe Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.3.4.2. Germany Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.3.4.3. Germany Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.3.5. UK
        • 7.3.5.1. UK Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.3.5.2. UK Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.3.5.3. UK Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.3.6. France
        • 7.3.6.1. France Sarcopenia Market revenue, by Supplement Type, 2024 - 2032 (USD Million)
        • 7.3.6.2. France Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032 (USD Million)
        • 7.3.6.3. France Sarcopenia Market revenue, by Region, 2024 - 2032 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Sarcopenia Market revenue, by Supplement Type, 2024 - 2032 (USD Million)
        • 7.3.7.2. Rest of Europe Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032 (USD Million)
        • 7.3.7.3. Rest of Europe Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
      • 7.4.2. Asia Pacific Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
      • 7.4.3. Asia Pacific Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.4.4.2. China Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.4.4.3. China Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.4.5.2. Japan Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.4.5.3. Japan Sarcopenia Market revenue, by region, 2024 - 2032(USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.4.6.2. India Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.4.6.3. India Sarcopenia Market revenue, by region, 2024 - 2032(USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.4.7.2. Rest of Asia Pacific Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.4.7.3. Rest of Asia Pacific Sarcopenia Market revenue, by region, 2024 - 2032(USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
      • 7.5.2. Latin America Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
      • 7.5.3. Latin America Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.5.4.2. Brazil Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.5.4.3. Brazil Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
        • 7.5.5.2. Rest of Latin America Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
        • 7.5.5.3. Rest of Latin America Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Sarcopenia Market revenue, by Supplement Type, 2024 - 2032(USD Million)
      • 7.6.2. The Middle East and Africa Sarcopenia Market revenue, by Distribution Channel, 2024 - 2032(USD Million)
      • 7.6.3. The Middle East and Africa Sarcopenia Market revenue, by Region, 2024 - 2032(USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Abbott Laboratories
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Application portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Pfizer Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Application portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Eli Lilly and Company
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Application portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Bayer AG
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Application portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Sanofi S.A.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Application portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. GlaxoSmithKline
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Application portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Novartis
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Application portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Cadila Healthcare
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Application portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Amway
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Application portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Sarcopenia Market revenue, 2024 – 2032 (USD Million) 
4. Porter’s Five Forces analysis
5. Sarcopenia Market attractiveness analysis, by Supplement Type segment
6. Sarcopenia Market attractiveness analysis, by Distribution Channel segment
7. Sarcopenia Market: Market attractiveness analysis, by Regional segment
8. Company market share analysis, 2024
9. Global Sarcopenia Market revenue share by Supplement Type, 2024 and 2032
10.  Global Sarcopenia Market, 2024 – 2032 (USD Million)
a. Global Protein Supplement market, 2024 – 2032(USD Million)
b. Global Vitamin D & Calcium Supplement market, 2024 – 2032(USD Million)
c. Global Vitamin B12 Supplement market, 2024 – 2032(USD Million)
11. Global Sarcopenia Market revenue share by Distribution Channel, 2024 and 2032
12. Global Sarcopenia Market, 2024 – 2032 (USD Million)
a. Hospital Pharmacies, 2024 – 2032(USD Million)
b. Retail Pharmacies, 2024 – 2032(USD Million)
c. Online Pharmacies, 2024 – 2032(USD Million)
d. Hypermarket & Supermarket, 2024 – 2032(USD Million)


Table Of Tables

List of Tables

1. Sarcopenia Market: Market Snapshot
2. Drivers of global Sarcopenia Market: Impact analysis 
3. Restraints of Sarcopenia Market: Impact analysis  
4. North America Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
5. North America Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
6. North America Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
7. The U.S. Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
8. The U.S. Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
9. The U.S. Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
10. Rest of North America Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
11. Rest of North America Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
12. Rest of North America Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
13. Europe Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
14. Europe Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
15. Europe Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
16. Germany Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
17. Germany Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
18. Germany Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
19. U.K. Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
20. U.K. Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
21. U.K. Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
22. France Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
23. France Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
24. France Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
25. Rest of Europe Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
26. Rest of Europe Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
27. Rest of Europe Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
28. Asia Pacific Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
29. Asia Pacific Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
30. Asia Pacific Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
31. China Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
32. China Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
33. China Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
34. Japan Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
35. Japan Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
36. Japan Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
37. India Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
38. India Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
39. India Sarcopenia Market revenue, by region, 2024 – 2032(USD Million)
40. Rest of Asia Pacific Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
41. Rest of Asia Pacific Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)
42. Rest of Asia Pacific Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
43. Latin America Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million)
44. Latin America Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)  
45. Latin America Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
46. Brazil Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
47. Brazil Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
48. Brazil Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million) 
49. Rest of Latin America Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
50. Rest of Latin America Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million) 
51. Rest of Latin America Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)
52. The Middle East and Africa Sarcopenia Market revenue, by Supplement Type, 2024 – 2032(USD Million) 
53. The Middle East and Africa Sarcopenia Market revenue, by Distribution Channel, 2024 – 2032(USD Million)  
54. The Middle East and Africa Sarcopenia Market revenue, by Region, 2024 – 2032(USD Million)

Methodology

FrequentlyAsked Questions

Sarcopenia is a condition associated with aging that leads to the loss of muscle mass and strength over time. It mostly affects people over the age of 30. Sarcopenia affects the quality of life reduces the level of physical activities, and causes a deficiency of vitamins and nutrition.

According to the report, the global sarcopenia market size was worth around USD 3019.14 million in 2023 and is predicted to grow to around USD 4855.01 million by 2032.

The global sarcopenia market is expected to grow at a CAGR of 5.42% during the forecast period.

The global sarcopenia market is dominated by players like Abbott Laboratories, Pfizer Inc., Eli Lilly and Company, Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Novartis, Cadila Healthcare, and Amway, among others.

The sarcopenia market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

  • zion payment modes

List of Contents

What is market size of Industry?Report ScopeCompetitive AnalysisThis report segments the global sarcopenia market as follows:

HappyClients